Medications

More than 2 dozen drugmakers to make Merck's COVID-19 pill

A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.

Diseases, Conditions, Syndromes

Pfizer/BioNTech to develop mRNA-based shingles shot

Germany's BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.

Vaccination

EU authorises Novavax as fifth COVID vaccine

The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.

Vaccination

EU set to back Novavax COVID vaccine

The EU's drug regulator will decide Monday whether to approve a COVID jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.

page 10 from 40